Retinitis Pigmentosa Treatment 2015
Current Treatment for Retinitis Pigmentosa is limited, but a number of expansions are poised to enter the field. Support on randomized clinical trials with vitamins and supplements, the only extensively suggested treatment is supplementation with high-dose vitamin A and fish oil, along with prevention of vitamin E, but these changes only delay degeneration.
The accessibility of the retina for comparatively safe surgical procedures and the immune privilege of the eye have made retinal diseases the perfect setting to utilize leading-edge tools, such as gene therapy and stem cell treatment, which have the possible to produce an effective treatment for some types of Retinitis Pigmentosa.
Dominantly inherited disorders are not readily amenable to Treatment Retinitis Pigmentosa using conventional gene supplementation therapy and autologous stem cell therapy, but they may be treatable using gene editing.
Gene supplementation therapy is unable to overcome the leading change in the same way that a heterozygous wild-type copy would be unsuccessful. In the same way, stem cells produced using cells obtained from the patient would produce mature cells that have the same propensity to degenerate as the patient’s cells, which would not be successful for aggressive forms of Retinitis Pigmentosa.